Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancer

Published:2016-11 Issue:2 Volume:480 Page:160-165
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Chen Xi,Xu Jin,Guo Qingcheng,Wang Lingfei,Yang Yun,Guo Huaizu,Gu Nana,Zhang Dapeng,Qian Weizhu,Hou Sheng,Li Jing,Dai Jianxin,Guo Yajun,Wang Hao

Funder

Natural Science Foundation of China

Ministry of Science and Technology of China

Shanghai Rising-star Program

Shanghai Key Laboratory of Cell Engineering

Shanghai Leading Academic Discipline Project

Shanghai Key technologies R&D Program

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference28 articles.

1. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

2. Advances in the treatment of non-small cell lung Cancer: focus on nivolumab, pembrolizumab, and atezolizumab;Leventakos;BioDrugs.,2016

3. Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer;Sheng;Sci. Rep.,2016

4. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012

5. Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2/neu expressing tumors;Helguera;Mol. Cancer Ther.,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific Targeting of Zinc Transporter LIV-1 with Immunocytokine Containing Anti-LIV-1 VHH and Human IL-2 and Evaluation of its In vitro Antitumor Activity;Current Pharmaceutical Design;2024-03

2. A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic;AMB Express;2024-02-09

3. Challenges to addressing the unmet medical needs for immunotherapy targeting cold colorectal cancer;World Journal of Gastrointestinal Oncology;2023-02-15

4. Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy;Frontiers in Immunology;2022-12-09

5. Engineering interferons and interleukins for cancer immunotherapy;Advanced Drug Delivery Reviews;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3